Form 4: Core Scientific CEO Adam Sullivan Receives Annual Restricted Stock Unit Grant

Core Scientific's CEO, Adam Sullivan, was granted 665,985 restricted stock units (RSUs) on April 28, 2025, according to a Form 4 filing.

Summary

• Adam Taylor Sullivan, CEO of Core Scientific, Inc., received an annual restricted stock unit (RSU) grant on April 28, 2025.
• The grant consists of 665,985 shares of common stock.
• One-third of the RSUs will vest on April 15, 2026, with the remaining two-thirds vesting in eight substantially equal quarterly installments thereafter.
• Vesting is contingent upon Sullivan's continued service to Core Scientific on each vesting date.
• Following the transaction, Sullivan beneficially owns 4,402,149 shares of Core Scientific common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects standard executive compensation practices and aligns management incentives with shareholder value. The grant itself is a positive sign of investment in the CEO's continued leadership.

Positives

• The RSU grant aligns the CEO's interests with the long-term performance of the company.
• Continued service requirement for vesting incentivizes the CEO to remain with the company.

Risks

• The value of the RSUs is dependent on the future stock price of Core Scientific, which is subject to market risks.
• If Sullivan leaves the company before the RSUs fully vest, he will forfeit the unvested portion.

Future Outlook

The vesting schedule of the RSUs extends into the future, incentivizing the CEO to remain with the company and drive long-term value.

Industry Context

Equity compensation is a common practice in the technology and cryptocurrency mining industries to attract and retain top talent. RSU grants are often used to align management's interests with those of shareholders.

Comparison to Industry Standards

• RSU grants are a standard form of executive compensation in publicly traded companies, particularly in growth-oriented sectors like technology and cryptocurrency mining.
• The vesting schedule described (one-third after one year, then quarterly) is a fairly typical vesting arrangement.
• Comparing the size of the grant to other companies requires analyzing Core Scientific's compensation policies relative to its peers, such as Marathon Digital Holdings (MARA) or Riot Platforms (RIOT), considering factors like market capitalization and executive performance.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the CEO to drive long-term value.
• Employees may see the grant as a sign of the company's commitment to its leadership.

Key Dates

Keywords

restricted stock units, RSU, Core Scientific, Adam Sullivan, CEO, beneficial ownership, Form 4, equity compensation, vesting